Mesotherapy

The document from 2010 provides an overview of mesotherapy, a technique for injecting substances into the mesoderm for medical and cosmetic purposes, including hair loss treatment. It describes the procedure as minimally invasive, virtually painless, and not requiring postoperative recovery. Mesotherapy uses a variety of substances, such as vitamins, amino acids, and drugs like minoxidil and finasteride, tailored to the treatment's purpose. While the procedure has gained popularity and is recognized by the French Academy of Medicine, it also carries potential risks like skin necrosis, infections, and allergic reactions. Case studies mentioned include a 42-year-old man who saw improvement in benign symmetric lipomatosis, a 40-year-old woman who developed delirium, and a 67-year-old man with acute orbital inflammation post-treatment. A study from Venezuela involving 49 cases highlighted a high incidence of infections caused by nontuberculous mycobacteria. The document calls for standardized solutions, FDA approval for active ingredients, further investigation into the procedure's effects, and emphasizes the need for aseptic techniques to prevent complications.